tiprankstipranks
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market
SYNACT
SynAct Pharma AB
RESEARCH TOOLSreports
Want to see SE:SYNACT full AI Analyst Report?

SynAct Pharma AB (SYNACT) Ratios

2 Followers

SynAct Pharma AB Ratios

SE:SYNACT's free cash flow for Q2 2025 was kr0.00. For the 2025 fiscal year, SE:SYNACT's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.74 3.31 3.30 3.01 9.34
Quick Ratio
 5.74 3.31 3.30 3.01 9.34
Cash Ratio
 4.41 2.48 2.15 2.50 7.21
Solvency Ratio
 -1.84 -2.19 -0.14 -4.15 -6.10
Operating Cash Flow Ratio
 -1.20 -4.52 -3.13 -4.02 -7.83
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -149.91 -173.02 -117.56
Net Current Asset Value
kr 41.40Mkr 21.12Mkr 37.65Mkr 23.23Mkr 124.16M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 <0.01 0.01 <0.01 <0.01 0.02
Debt-to-Capital Ratio
 <0.01 0.01 <0.01 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.23 1.29 1.26 1.29 1.13
Debt Service Coverage Ratio
 -217.75 -44.21 -4.93 -155.69 -75.62
Interest Coverage Ratio
 -233.56 -47.80 -109.73 -281.68 -359.54
Debt to Market Cap
 0.00 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.03 0.08 0.07 0.04 0.09
Net Debt to EBITDA
 0.54 0.44 3.85 0.28 1.00
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
93.64%93.14%90.73%96.23%92.66%
EBT Per EBIT
99.69%101.57%100.94%99.90%101.29%
Return on Assets (ROA)
-46.93%-50.26%-30.46%-94.65%-69.57%
Return on Equity (ROE)
-59.12%-65.08%-38.47%-122.49%-78.41%
Return on Capital Employed (ROCE)
-53.63%-58.87%-37.17%-110.55%-82.85%
Return on Invested Capital (ROIC)
-50.08%-54.66%-33.56%-105.77%-75.58%
Return on Tangible Assets
-128.69%-152.45%-71.08%-284.48%-69.57%
Earnings Yield
-19.57%-9.60%-23.24%-74.14%-4.41%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.04 0.08 0.23
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 0.00 0.00 -10.26K -4.54K -1.62K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 10.26K 4.54K 1.62K
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.33 -1.91 -2.26 -3.08 -4.26
Free Cash Flow Per Share
 -0.33 -1.91 -2.26 -3.08 -4.26
CapEx Per Share
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -16.64 -53.89 -47.42 -157.26 -56.95
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-3.15%-8.43%-25.15%-34.42%-5.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -9.84 -10.41 -4.31 -1.35 -22.66
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 5.82 6.78 1.66 1.65 17.77
Price-to-Free Cash Flow (P/FCF) Ratio
 -62.72 -11.86 -3.98 -2.91 -19.12
Price-to-Operating Cash Flow Ratio
 -63.20 -11.86 -3.98 -2.91 -19.12
Price-to-Earnings Growth (PEG) Ratio
 0.88 -2.41 0.06 -0.02 -0.65
Price-to-Fair Value
 5.82 6.78 1.66 1.65 17.77
Enterprise Value Multiple
 -8.85 -9.46 -19.18 -1.03 -20.26
Enterprise Value
 501.49M 1.10B 295.28M 229.32M 2.14B
EV to EBITDA
 -4.21 -9.46 -19.18 -1.03 -20.26
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -28.13 -11.33 -3.31 -2.29 -18.22
EV to Operating Cash Flow
 -28.13 -11.33 -3.31 -2.29 -18.22
Tangible Book Value Per Share
 0.80 0.44 1.51 0.74 4.59
Shareholders’ Equity Per Share
 3.62 3.33 5.42 5.42 4.59
Tax and Other Ratios
Effective Tax Rate
 0.06 0.07 0.09 0.04 0.07
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -2.09 -2.17 -2.08 -6.64 -3.60
Tax Burden
 0.94 0.93 0.91 0.96 0.93
Interest Burden
 1.00 1.02 1.01 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.24 0.84 0.99 0.46 1.11
Currency in SEK